Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/46391
Title: Identification and prospective validation of clinically relevant chronic obstructive pulmonary disease (COPD) subtypes.
Author: García Aymerich, Judith
Gomez, Federico P.
Benet Mora, Marta
Farrero, Eva
Basagaña, Xavier
Gayete, Àngel
Pare i Bardera, J. Carles
Freixa, Xavier
Ferrer, Jaume
Ferrer Monreal, Antonio
Roca Elias, Josep
Galdiz, Juan B.
Sauleda, Jaume
Monsó, Eduard
Gea Guiral, Joaquim
Barberà i Mir, Joan Albert
Agustí García-Navarro, Àlvar
Antó i Boqué, Josep Maria
Keywords: Malalties de l'aparell respiratori.
Malalties pulmonars obstructives cròniques.
Assaigs clínics.
Respiratory diseases.
Chronic obstructive pulmonary diseases.
Clinical trials.
Issue Date: 21-Dec-2010
Publisher: BMJ Publishing Group
Abstract: Background Chronic obstructive pulmonary disease (COPD) is increasingly considered a heterogeneous condition. It was hypothesised that COPD, as currently defined, includes different clinically relevant subtypes. Methods To identify and validate COPD subtypes, 342 subjects hospitalised for the first time because of a COPD exacerbation were recruited. Three months after discharge, when clinically stable, symptoms and quality of life, lung function, exercise capacity, nutritional status, biomarkers of systemic and bronchial inflammation, sputum microbiology, CT of the thorax and echocardiography were assessed. COPD groups were identified by partitioning cluster analysis and validated prospectively against cause-specific hospitalisations and all-cause mortality during a 4 year follow-up. Results Three COPD groups were identified: group 1 (n ¼ 126, 67 years) was characterised by severe airflow limitation (postbronchodilator forced expiratory volume in 1 s (FEV 1 ) 38% predicted) and worse performance in most of the respiratory domains of the disease; group 2 (n ¼ 125, 69 years) showed milder airflow limitation (FEV 1 63% predicted); and group 3 (n ¼ 91, 67 years) combined a similarly milder airflow limitation (FEV 1 58% predicted) with a high proportion of obesity, cardiovascular disorders, iabetes and systemic inflammation. During follow-up, group 1 had more frequent hospitalisations due to COPD (HR 3.28, p < 0.001) and higher all-cause mortality (HR 2.36, p ¼ 0.018) than the other two groups, whereas group 3 had more admissions due to cardiovascular disease (HR 2.87, p ¼ 0.014). Conclusions In patients with COPD recruited at their first hospitalisation, three different COPD subtypes were identified and prospectively validated:"severe respiratory COPD","moderate respiratory COPD", and"systemic COPD'
Note: Reproducció del document publicat a: http://dx.doi.org/10.1136/thx.2010.154484
It is part of: Thorax, 2010, vol. 66, p. 430-437
Related resource: http://dx.doi.org/10.1136/thx.2010.154484
URI: http://hdl.handle.net/2445/46391
ISSN: 0040-6376
Appears in Collections:Articles publicats en revistes (Medicina)

Files in This Item:
File Description SizeFormat 
609851.pdf535.18 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.